At the light source BESSY II, researchers gain important insights into the corona virus. How do they do that? Our expert Manfred Weiss explains on the HZB YouTube channel how protein crystallography works. All important information about the SARS-CoV-2 research at BESSY II can be found here.
How does BESSY II contribute to the research on SARS-CoV-2?
Digital walk through BESSY II
How does an accelerator actually look from the inside? And how is the highly desired X-ray light produced, which researchers from all over the world use? Join us on a tour of the electron storage ring BESSY II in Adlershof, which produces the brightest light in Berlin! Link to the video
Achieving climate targets with building integrated photovoltaics
In cities with multi-storey construction, roof areas are not sufficient to cover the electricity demand with photovoltaics. Active facade elements make additional areas usable. So far, however, such building-integrated PV modules have rarely been installed. The Advisory Centre for Building Integrated Photovoltaics (BAIP) at the HZB wants to change this. Blog post building integrated photovoltaics
The athlete in the lab coat
Steve Albrecht is researching on perovskite solar cells and holds several efficiency world records with his team. Back in his schooldays, he was going to become either a competitive gymnast or a scientist. He chose science, but the same athletic ambition still drives his research forward.
The route to BESSY III
At HZB we have the experts for designing and building a new accelerator source, and we have many creative scientists onboard, who are making advancements in the development of photon research. The new source BESSY III is planned go into operation in 2030. Our aim is to offer worldwide unique experiments that will accelerate the gaining of new insights in many disciplines.
Patients with eye tumours are being treated with proton beams since June 1998 by the Charité Universitätsklinikum Benjamin Franklin together with the Helmholtz-Zentrum Berlin. Especially, we succeed to destroy the tumour in more than 97 percent of the patients. Eye tumour therapy with protons